ORIC Pharmaceuticals, Inc.
Price Action
Technical Summary
WEAKENINGORIC Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 37), showing significant lag compared to the market leaders. Earnings growth of 19% provides fundamental context to the price action. Investors should exercise caution due to high volatility (80% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $8.47 | +19.92% | ABOVE |
| 50 SMA | $8.92 | +13.80% | ABOVE |
| 100 SMA | $10.12 | +0.30% | ABOVE |
| 150 SMA | $10.13 | +0.25% | ABOVE |
| 200 SMA | $10.66 | -4.77% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ORIC in an uptrend right now?
ORIC has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ORIC overbought or oversold?
ORIC's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.
Is ORIC outperforming the market?
ORIC has a Relative Strength (RS) Rating of 37 out of 99. ORIC is currently lagging the broader market.
Where is ORIC in its 52-week range?
ORIC is trading at $10.15, which is 68% of its 52-week high ($14.93) and 38% above its 52-week low ($7.23).
How volatile is ORIC?
ORIC has a Beta of 1.14 and 52-week volatility of 80%. It's more volatile than the S&P 500 - expect bigger swings.